| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―12 |
Assessing the impact of COVID-19 on diabetic retinopathy in Fiji: A 5-year review |
Subash Bhatta, Nayana Pant, Telaite B. Keteca |
| 2 |
[GO] |
2023―Dec―14 |
Impact of COVID-19 on ophthalmic medical access during successive waves: Demographics, disease factors, and wave locations |
Kwanghyun Lee, Young Min Park, Jung-Kyu Choi, Jaekwang Lee |
| 3 |
[GO] |
2023―Aug―30 |
Real-world outcomes of low-dose atropine therapy on myopia progression in an Australian cohort during the COVID-19 pandemic |
Eiman Usmani, Stephanie Callisto, Weng Onn Chan, Deepa Taranath |
| 4 |
[GO] |
2020―Nov―01 |
SARS-CoV
-2 and
COVID
-19 for the ophthalmologist |
Camilo Brandão-de-Resende, Alberto Diniz-Filho, Fabiano Almeida Brito, Daniel V. Vasconcelos-Santos |
| 5 |
[GO] |
2020―Oct―29 |
Telehealth in an acute ophthalmic setting during COVID-19 lock-down |
Danny Lam, Catriona Downie, Elisa Cornish, Peter McCluskey, Sophia L. Zagora |
| 6 |
[GO] |
2020―Sep―14 |
Proof-of-concept calculations to determine the health-adjusted life-year trade-off between intravitreal Anti-VEGF Injections and transmission of COVID-19 |
Matt J. Boyd, Daniel A.R. Scott, David M. Squirrell, Graham A. Wilson |
| 7 |
[GO] |
2020―Aug―28 |
Cataract surgical patients as a candidate sentinel population for SARS-CoV-2 surveillance |
Joshua Foreman, Myra McGuinness, David A. Mackey, Peter Wijngaarden |
